Clinical Trial Update: Evaluation of Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk [NA]

View source ↗

Summary

This clinical trial update notes the safety and performance evaluation of the Omega LAA Occluder and its Delivery System in patients with non-valvular atrial fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• Omega Delivery System
• Omega LAA Occluder

Snippet

Sponsor: Eclipse Medical Ltd. | Conditions: Non-Valvular Atrial Fibrillation | NA | Status: ACTIVE_NOT_RECRUITING